Julian Perelman

 

Contactos

Telefone: 21 751 21 00
E-mail: JPerelman@ensp.unl.pt

 

Áreas de Interesse

My main areas of interest are the inequalities in health and health care, and the search for the causes of inequalities; the impact of health care providers' financing, with a focus on equity-related effects; the economic evaluation in health; and the determinants of health care expenditures. My research is essentially empirical, with the use of applied econometric methods, and a particular interest in natural experiments and policy evaluation.

 

Ensino 

Economia da saúde

Applied Health Economics

Análise económica dos sistemas de saúde

Avaliação económica em saúde

Equidade e desigualdade em saúde

Economia hospitalar

 

Investigação (projectos em curso) 

  • Reassessing the Portuguese mental health system: evaluating its performance, and designing a new financial and organizational model aimed at enhancing its equity, efficiency, and quality (projeto EEA Grants, Programa Iniciativas em Saúde Pública PT06, 000065SM1).
  • Cost-effectiveness of HIV testing in non-health care settings (Community Based Voluntary Counselling and Testing services) – Euro HIV EDAT Project (GILEAD goShape)
  • Enhancing the effectiveness of programs and strategies to prevent smoking by adolescents: a realist evaluation comparing seven European countries (SILNE-R, HORIZON 2020 635056)
  • Do teste VIH ao tratamento VIH – o caminho da referênciação e seus determinantes (projecto FCT, VIH/SAU/0065/2011).
  • Tackling socioeconomic inequalities in smoking: learning from natural experiments by time trend analyses and cross-national comparisons (SILNE, FP7-HEALTH-2011.3.3-1).
  • "Pay-for-performance" e equidade nos cuidados de saúde (financiado pelo Instituto Nacional de Saúde, 2011EXT484).
  • Análise económica da estratégia de aconselhamento e detecção precoce da infecção VIH/sida em Portugal (financiado pelo Alto Comissariado da Saúde Coordenação Nacional para a Infecção VIH/sida). 

     

 Publicações (mais relevantes)

  

  •  Baptista A, Teixeira I, Romano S, Vaz Carneiro A, Perelman J. The place of DPP-4 inhibitors in the treatment algorithm of diabetes type 2: a systematic review of cost-effectiveness studies. European Journal of Health Economics, published online ahead-of-print 17-10-2016.
  • Lorant V, Soto-Rojas V, Bécares L, Kinnunen J, Kuipers MA, Moor I, Roscillo G, Alves J, Grard A, Rimpela AH, Federico B, Richter M, Perelman J, Kunst AE. A social network analysis of substance use among immigrant adolescents in six European cities. Social Science and Medicine 2016, 169:58-65.
  • Russo G, Rego I, Perelman J, Pita Barros P. A tale of loss of privilege, resilience and change: the impact of the economic crisis on physicians and medical services in Portugal. Health Policy 2016, 120(9):1079-1086.
  •  Lorant V, Soto-Rojas V, Robert PO, Kinnunen J, Kuipers MA, Moor I, Roscillo G, Alves J, Rimpela AH, Federico B, Richter M, Perelman J, Kunst AE. Social network and inequalities in smoking amongst school-aged adolescents in six European countries. International Journal of Public Health, published online ahead-of-print 12-5-2016.
  • Alves J, Perelman J, Soto-Rojas V, Richter M, Rimpela AH, Loureiro I, Federico B, Kuipers MA, Kunst AE, Lorant V. The role of parental smoking on adolescent smoking and its social patterning: a cross-sectional survey in six European cities. Journal of Public Health, published online ahead-of-print 8-5-2016.
  •  Kuipers MA, Robert PO, Richter M, Rathmann K, Rimpela AH, Perelman J, Federico B, Lorant V, Kunst AE. Individual and contextual determinants of perceived peer smoking prevalence among adolescents in six European cities. Preventive Medicine2016, 88:168-175.
  •  Kinnunen J, Lindfors P, Rimpela AH, Salmela-Aro K, Rathmann K, Perelman J, Federico B, Richter M, Kunst AE, Lorant V. Academic well-being and smoking among 14- to 17-year-old schoolchildren in six European cities. Journal of Adolescence 2016, 50:56-64.
  • Cristina A, Alves J, Perelman J. Desigualdades socioeconómicas no tabagismo em jovens dos 15 aos 17 anos. Revista Portuguesa de Saúde Pública 2016, 34(1):69-76.
  • Campos-Matos I, Russo G, Perelman J. Connecting the dots on health inequalities – a systematic review on the social determinants of health in Portugal. International Journal for Equity in Health 2016, 15-26.
  • Kuipers MA, de Korte R, Soto VE, Richter M, Moor I, Rimpela AH, Perelman J, Federico B, Kunst AE, Loran V. School smoking policies and educational inequalities in smoking behaviour of adolescents aged 14–17 years in Europe. Journal of Epidemiology and Community Health 2016, 70:132-139.
  • Alves J, Nunes C, Perelman J. Socio-economic inequalities in tobacco-related diseases in Portugal: an ecological approach. Public Health 2016, 130:36-42.
  • Marques AP, Macedo AF, Perelman J, Aguiar P, Rocha-Sousa A, Santana R. Diffusion of anti-VEGF injections in the Portuguese National Health System. BMJ Open 2015, 5:e009006.
  • Perelman J. Liberdade de escolha no Serviço Nacional de Saúde – O caso do VIH. Acta Médica Portuguesa 2015, 28(2):138-140.
  • Moureaux C, Perelman J, da Costa EM, Roch I, Annemans L, Heymans I, Closon M. C. Impact of the Medical Home Model on the Quality of Primary Care: The Belgian Experience. Medical Care 2015, 53(5):396-400.
  • Alves, J, Kunst AE, Perelman J. Evolution of socioeconomic inequalities in smoking: results from the Portuguese national health interview surveys. BMC Public Health 2015, 15(1): 311.
  • Lorant V, Soto VE, Alves J, Federico B, Kinnunen J, Kuipers M, Moor I, Perelman J, Richter M, Rimpela A, Robert PO, Roscillo G, Kunst AE. Smoking in school-aged adolescents: design of a social network survey in six European countries. BMC Research Notes 2015, 8(1), 91.
  • Perelman J, Felix S, Santana R. The Great Recession in Portugal: Impact on hospital care use. Health Policy 2015, 119:307-315.
  • Perelman J. Are chronic diseases related to height? Economics and Human Biology 2014, 15:56-66.
  • Mendonça L, Perelman J, Rodrigues V, Fragata J. Cost-effectiveness of lung transplantation and its evolution: the Portuguese case. The European Journal of Health Economics 2014, 15:767-772.
  • Goulão C, Perelman J. The interaction between a public and a duplicate private provider of health services. In: Anthony J. Culyer (ed.), Encyclopedia of Health Economics, vol. 2, San Diego: Elsevier, 2014: 72-82.
  • Yazdanpanah Y, Perelman J, Dilorenzo M, Alves J, Barros H, Mateus M, Pereira J, Mansinho K, Robine M, Park J, Ross E, Losina E, Walensky R, Noubary F, Freedberg K, Paltiel D. Routine HIV Screening in Portugal: Clinical Impact and Cost-Effectiveness. PloS ONE 2013, 8(12):e84173.
  • Perelman J, Alves J, Miranda A-C., Mateus C, Mansinho K, Antunes F, Oliveira J, Poças J, Doroana M, Marques R, Teófilo E, Pereira J. Direct treatment costs of HIV/AIDS in Portugal. Revista de Saúde Pública 2013, 47(5):865-872.
  • Perelman J, Roch I, Heymans I, Moureaux C, Lagasse R, Annemans L, Closon MC. Medical Homes Versus Individual Practice in Primary Care: Impact on Health Care Expenditures. Medical Care 2013, 51(8):682-688.
  • Alves J, Peralta S, Perelman J. Efficiency and equity consequences of decentralization in health: an economic perspective. Revista Portuguesa de Saúde Pública 2013, 31(1): 74-83.
  • Perelman J, Alexandre A, Mateus C. Gender disparities in health and health care: results from the Portuguese National Health Interview Survey. Cadernos de Saúde Pública 2012, 28(12):2339-2348.
  • Perelman J, Closon MC. Impact of socio-economic factors on in-patient length of stay and consequences in per-case payment systems. Journal of Health Services Research and Policy 2011, 16(4): 197-202.
  • Perelman J, Mateus C, Alexandre A. Gender equity in treatment for cardiac heart disease in Portugal. Social Science and Medicine 2010, 71:25-29.
  • Fernandes A, Perelman J, Mateus C. Health and health care in Portugal: does gender matter? Instituto Nacional Ricardo Jorge, Lisboa, 2010.
  • Perelman J, Shmueli A, McDonald K, Pilote L, Saynina O, Closon MC and the TECH Group. Inequality in treatment use among elderly patients with acute myocardial infarction: USA, Belgium and Quebec. BMC Health Services Research 2009, 9:130.
  • Bech M, Christiansen T, Dunham K, Lauridsen J, Lyttkens CH, McDonald K, McGuire A. The influence of economic incentives and regulatory factors on the adoption of treatment technologies: a case study of technologies used to treat health attack. Health Economics, 2009, 18(10):1114-32, as member of the TECH Research Network.
  • Perelman J, Shmueli A, Closon MC. Deriving a risk-adjustment formula for hospital financing integrating the impact of socioeconomic status on length of stay. Social Science and Medicine 2008, 66(1):88-98.
  • Closon M-C, France R, Perelman J. Introduction and use of DRGs in Belgium. In: Kimberly, J; Pouvourville G., eds. Globalization of Managerial Innovation in Health Care. Londres: Cambridge University Press, 2008.
  • Perelman J, Closon MC. Hospital response to prospective financing of in-patient days: the Belgian case. Health Policy 2007, 84(2-3): 200-9.
  • Maes N, De Coster P, Closon M-C, Perelman J. Technological change in heart attack care in Belgium: causes and consequences. In: Technological change in health care – A global analysis of heart attack, McClellan and Kessler eds., University of Michigan Press, 2002.
  • TECH Research Network. Technological change around the world: evidence from heart attack care. Health Affairs 2001, May/June, 20(3): 25-42, as member of the TECH Research Network.

 

 

 Outros Dados Curriculares (C.V.) 

 

  • Professor Auxiliar da Escola Nacional de Saúde Pública (Universidade Nova de Lisboa)
  • Membro do IRSS (Institut de Recherche en Santé et Société)
  • Doutorado em economia da Université Catholique de Louvain (Janeiro 2005)

     

     

 

 

Atualizado em  outubro de 2016